# OnCo record rabacfosadine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rabacfosadine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rabacfosadine" ;
  schema:name "Rabacfosadine"@en ;
  schema:alternateName "Tanovea"@en, "Tanovea-CA1"@en, "rabacfosadine for injection"@en, "Tanovea" ;
  schema:description "Rabacfosadine (Tanovea) is an intravenous drip for dogs with lymphoma, conditionally approved by the US Food and Drug Administration in 2016 and fully approved in 2021. It is a medicine for dogs and is not used in people."@en ;
  schema:url <https://onco.cc/drugs/rabacfosadine/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.fda.gov/consumers/consumer-updates/my-dog-has-cancer-what-do-i-need-know>, <https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/11083> ;
  onco:tag "veterinary", "comparative-oncology" ;
  onco:modality "small molecule (nucleotide analogue)" ;
  onco:related <https://onco.cc/ideas/idea-bio1-comparative-oncology-dogs/>, <https://onco.cc/journals/veterinary-and-comparative-oncology/> .